Related Experiment Video
Updated: May 13, 2026

09:34
Structured Motor Rehabilitation After Selective Nerve Transfers
Published on: August 15, 2019
23.0K
Functional Outcomes After Reoperation for Recurrent Glioma: A Systematic Review and Meta-Analysis of Karnofsky
Brooklyn Brekke-Kumley1, Kamel Chebaro2, Kristin Cler1
1Montana College of Osteopathic Medicine, Rocky Vista University, Billings, MT 59106, USA.
Cancers
|January 10, 2026
Summary
Reoperation for recurrent glioma does not consistently worsen functional status, but outcomes vary significantly. More research is needed to understand health-related quality of life (HRQoL) after these procedures.
Area of Science:
- Neurosurgery
- Oncology
- Quality of Life Research
Background:
- Gliomas are common adult primary brain tumors with variable recurrence rates.
- Reoperation is a key strategy for managing glioma recurrence.
- The impact of reoperation on functional status and quality of life is not well-defined.
Purpose of the Study:
- To systematically review evidence on postoperative functional outcomes after glioma reoperation.
- To summarize health-related quality of life (HRQoL) reporting in the reoperation literature.
Main Methods:
- Systematic search of PubMed and Google Scholar (1336 articles retrieved).
- 15 studies (1934 patients) met inclusion criteria, using validated functional or HRQoL instruments.
- Meta-analysis of Karnofsky Performance Status (KPS); descriptive summary of HRQoL measures due to heterogeneity.
Main Results:
- Random-effects model showed no significant overall change in KPS after reoperation (+0.16 KPS).
- High heterogeneity (I² ≈ 48%) and wide prediction intervals (-14.1 to +14.4) indicate significant variability in outcomes.
- Sensitivity analyses did not materially alter results after excluding an outlier study.
Conclusions:
- Glioma reoperation is not consistently associated with functional decline (KPS), despite significant outcome variability.
- Health-related quality of life (HRQoL) reporting is sparse and inconsistent.
- Prospective, multicenter studies with standardized HRQoL instruments are needed to clarify post-reoperation quality-of-life trajectories.

